S&P 500 retreats from record high
Posted: March 22, 2014 at 3:51 a.m.
NEW YORK — An early surge on the stock market evaporated Friday, as healthcare stocks tugged major indexes down. Biotech companies were especially hard-hit after lawmakers questioned the pricing of a hepatitis-C drug made by Gilead Sciences.
This story is only available from our archives.
Business, Pages 28 on 03/22/2014